Certified by Founder Lodge
Braveheart Bio
United States - San Francisco, California
START UP
1 Disclosed Funding Rounds $185,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life s
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 06 ,2025 | Series A | $185,000,000 |
Enavate Sciences
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Leona Health | $14,000,000 | (Dec 18, 2025)
Drive Health | $15,000,000 | (Dec 18, 2025)
Codoxo | $35,000,000 | (Dec 18, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Limenet | $8,217,860 | (Dec 18, 2025)
